Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FYFM3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,528
Award facts
- Contract value 100% obligated
- $51,528.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $51,528.00 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and chronic rhinosinusitis with nasal polyps, making it a critical pharmaceutical component of military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp maintains a substantial portfolio of federal contracts supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a diverse range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's selection through competitive procurement demonstrates its established capability to meet stringent federal pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FYFM3?
SPE2DB25FYFM3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FYFM3 worth?
The government has obligated $51,528 on SPE2DB25FYFM3.
Is contract SPE2DB25FYFM3 an order under another contract?
Yes. SPE2DB25FYFM3 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYFM3 competed?
The extent of competition for SPE2DB25FYFM3 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award